Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 28, 2021

SELL
$7.54 - $9.79 $93,375 - $121,239
-12,384 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$4.76 - $11.25 $49,104 - $116,055
-10,316 Reduced 45.44%
12,384 $119,000
Q4 2020

Jan 25, 2021

SELL
$2.43 - $5.42 $25,029 - $55,826
-10,300 Reduced 31.21%
22,700 $110,000
Q2 2020

Aug 05, 2020

BUY
$1.33 - $3.63 $43,890 - $119,790
33,000 New
33,000 $102,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Vanguard Capital Wealth Advisors Portfolio

Follow Vanguard Capital Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.